Published on January 8, 2010 at 2:06 AM
Sciele Pharma, Inc., a Shionogi company, today announced the U.S.
availability of Adrenaclick™, a single-dose, epinephrine auto-injector
for the emergency treatment for severe allergic reactions (Type I) such
as anaphylaxis. Adrenaclick™ will be available as a single unit or a
convenient Two-Pack. It is also available in two dosing options (0.15 mg
and 0.3 mg).
Adrenaclick™ delivers epinephrine, the drug of choice for anaphylactic
reactions, with the use of an auto-injector. The Adrenaclick™
auto-injector is designed to ensure accurate delivery of epinephrine in
the thigh through a “press-and-hold” administration technique. It is
also designed for ease-of-use with clearly labeled caps, a red injector
tip, and color-coded instructions on the side of the unit. Sciele is
also offering free training information to help educate patients on the
proper administration; full details are available online at www.adrenaclick.com.
http://www.sciele.com/
72defd84-be51-44d5-b3b1-8bf71381a43b|0|.0
Posted in: Medical Condition News | Pharmaceutical News
Tags: Allergy, Anaphylaxis, Angina, Anxiety, Asthma, Cancer, Cholesterol, Diabetes, Exercise, Headache, Immunotherapy, Nausea, Pediatrics, Type 2 Diabetes, Vomiting